BioSpace News Archive

The awarded paper won the highest scientific merits out of 577 conference papers submitted this year

Strategies include expanded access to education and mental health services, while raising new revenue to pay for them.

30-50 patients in additional arm will be investigated under the collaboration

The transaction is expected to close during the third quarter of 2018.

Centrexion Therapeutics Corporation announced that Nick Harvey has been appointed Chief Financial Officer of the company.

OncoSec Medical Incorporated announced the appointment of Robert W. Ashworth, Ph.D. as Vice President, Regulatory.

Judge Recommends Exclusion Order to Prevent Importation and Cease-and-Desist Order to Prevent Further Sale and Marketing of Infringing Products in the United States

July 30, 2018 12:00 UTC Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer Selects Bladder Cancer as Third ADXS-HOT Drug Candidate to Take into the Clinic after Non-Small Cell Lung and Prostate Cancers Advances Goal to Have Five Neoantigen-Based Drug Candidates in Clinical Evaluation by 4Q 2019 PRINCETON, N.J.--( BUSINESS WIRE )-- Advaxis,

Hitgen Ltd. is pleased to announce that the company has extended and expanded its agreement with MSD, known as Merck & Co., Inc, Kenilworth NJ., USA into a multi-year research collaboration and license agreement to build and screen novel DNA-encoded libraries (DELs) in order to discover potential unique small molecule assets to be used in drug discovery and development.

Rockwell Medical, Inc. announced that the Audit Committee of its Board of Directors has engaged Marcum LLP as Rockwell Medical’s new independent registered public accounting firm.